vimarsana.com

Latest Breaking News On - Precision medicine in oncology - Page 1 : vimarsana.com

Acalabrutinib Yields Long-Term Efficacy in a Pooled Analysis of Higher-Risk CLL

Dr Amini on High-Risk Factors Associated With Cardiac Toxicities in Lung Cancer

Dr Kim on the Importance of the FDA Approval of Repotrectinib for ROS1+ NSCLC

Chul Kim, MD, MPH, discusses the impact of optimizing rare targets in lung cancer, highlighting the FDA approval of repotrectinib in ROS1-positive disease.

Practical Toxicity Management Awareness With FGFR Inhibitors Improves Real-World Patient Outcomes

Vivek Subbiah, MD, emphasizes the need for improved guidance on practical toxicity management for various FGFR-altered malignancies, highlights best practices for monitoring and managing the most common on-target toxicities associated with FGFR inhibitors, and discusses the key implications of this review for those utilizing FGFR inhibitors.

Dr Ip on the Importance of NGS Testing in Hematologic Malignancies

Andrew Ip, MD, discusses findings from a study on the use of next-generation sequencing of flow cytometry CD markers and machine learning as a replacement to flow cytometry analysis for the diagnosis of hematologic neoplasms.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.